Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
589 Feuchtinger, A
52-year-old male, BMI 28, HbA1c 7.2%, biopsy-confirmed NASH with F2 fibrosis, ALT 89
If Phase 3 results confirm its efficacy and safety, it could represent a meaningful advance in metabolic medicine
The subunits will display different actions, as 0 will lead to inactivation of Ca2+ voltage related channels and K+ channels
US$ 20.99
US$ 23.39
US$ 29.04
US$ 29.40
US$ 24.32
US$ 25.49
US$ 29.60
